JPRN-UMIN000033924已完成未知
Retrospective chart review on natalizumab: Efficacy and safety of long-term treatment with natalizumab in Japanese patients with RRMS - Retrospective chart review on long-term treatment with natalizumab in Japanese patients with RRMS
IRINO MEDICAL CLINIC, LLC0 个研究点目标入组 85 人开始时间: 2018年8月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 85
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Refusal of consent by opt-out prior to the initiation of the study
研究者
相似试验
终止
2 期
Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving MethotrexateRheumatoid ArthritisNCT00083759Biogen299
已完成
不适用
The effect of natalizumab treatment on functional adaptation in multiple sclerosis (MS)MS1000381610012303Multiple SclerosisNL-OMON40114Vrije Universiteit Medisch Centrum60
已完成
2 期
Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's DiseaseCrohn's DiseaseNCT00055536Biogen60
招募中
2 期
To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma.Ewing's sarcoma2024-514441-11-00Instytut Matki I Dziecka24
招募中
1 期
To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma.Ewing's sarcomaCTIS2024-514441-11-00Instytut Matki I Dziecka24